Paula Soteropoulos
Director/Board Member at UNIQURE N.V.
Net worth: 115 541 $ as of 2024-03-30
Profile
Paula Soteropoulos is currently the Chairman at Ensoma, Inc. and an Independent Non-Executive Director at uniQure NV.
She also holds director positions at JFYNetworks, Inc., Rallybio LLC, Dianthus Therapeutics OpCo, Inc., Rallybio Corp., Dianthus Therapeutics, Inc., Kyowa Kirin, Inc., and 5AM Venture Management LLC.
In her former roles, Ms. Soteropoulos served as the Chief Executive Officer & Director at Akcea Therapeutics, Inc., Vice President & GM-Global Cardiovascular Business at Genzyme Corp., and Senior Vice President & GM-Strategic Alliances at Moderna, Inc.Ms. Soteropoulos completed her undergraduate and graduate degrees at Tufts University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
UNIQURE N.V.
0.03% | 2023-09-14 | 13,723 ( 0.03% ) | 71 360 $ | 2024-03-30 |
RALLYBIO CORPORATION
0.06% | 2023-05-16 | 23,882 ( 0.06% ) | 44 182 $ | 2024-03-30 |
| 2023-09-10 | 0 ( -.--% ) | - $ | 2024-03-30 |
Paula Soteropoulos active positions
| Companies | Position | Start |
|---|---|---|
| UNIQURE N.V. | Director/Board Member | 2013-06-30 |
| RALLYBIO CORPORATION | Director/Board Member | 2020-09-30 |
| DIANTHUS THERAPEUTICS, INC. | Director/Board Member | 2023-09-10 |
| JFYNetworks, Inc | Director/Board Member | - |
Rallybio LLC
 Rallybio LLC Miscellaneous Commercial ServicesCommercial Services Rallybio LLC operates as a development-stage biotechnology company. The firm develops transformative therapies for patients. It focuses on bringing life-transforming medicines to patients with devastating and rare disorder. The company was founded by Martin Mackay, Stephen Uden and Jeffrey Fryer in 2018 and is headquartered in Farmington, CT. | Director/Board Member | 2020-11-01 |
Dianthus Therapeutics, Inc. (Massachusetts)
 Dianthus Therapeutics, Inc. (Massachusetts) BiotechnologyHealth Technology Dianthus Therapeutics OpCo, Inc. provides heath care services. The company was founded by Jonathan Violin and is headquartered in Waltham, MA. | Director/Board Member | - |
5AM Venture Management LLC
 5AM Venture Management LLC Investment ManagersFinance 5AM Venture Management LLC (5AM Ventures) is an Independent Venture Capital firm founded in 2002 by Andrew J. Schwab, Carin M. Rollins and John D. Diekman. The firm is headquartered in San Francisco, US. | Consultant / Advisor | 2019-12-31 |
Ensoma, Inc.
 Ensoma, Inc. Miscellaneous Commercial ServicesCommercial Services Ensoma, Inc. believes in the future of medicine and is committed to creating a new therapeutic category to tackle diseases that affect millions around the world, such as cancer and autoimmune disease, as well as inherited conditions. Ensoma is based in Boston, MA and has subsidiaries in Denmark. The company's engenious™ platform combines innovative delivery technology with the full DNA editing toolkit to address these disorders. Ensoma is supported by top-tier investors, a strategic collaboration with Takeda, and a passionate team. The company was founded by André Lieber, Hans-Peter Kiem, Kush M. Parmar, and the CEO is Emile F. Nuwaysir. | Chairman | 2020-02-29 |
| Kyowa Kirin, Inc. | Director/Board Member | 2021-08-31 |
Former positions of Paula Soteropoulos
| Companies | Position | End |
|---|---|---|
| ░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Training of Paula Soteropoulos
| Tufts University | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 4 |
|---|---|
| UNIQURE N.V. | Health Technology |
| MODERNA, INC. | Health Technology |
| RALLYBIO CORPORATION | Health Technology |
| DIANTHUS THERAPEUTICS, INC. | Health Technology |
| Private companies | 8 |
|---|---|
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
5AM Venture Management LLC
5AM Venture Management LLC Investment ManagersFinance 5AM Venture Management LLC (5AM Ventures) is an Independent Venture Capital firm founded in 2002 by Andrew J. Schwab, Carin M. Rollins and John D. Diekman. The firm is headquartered in San Francisco, US. | Finance |
Akcea Therapeutics, Inc.
 Akcea Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Akcea Therapeutics, Inc. is a biopharmaceutical company. It engages in the development and marketing of drugs globally to treat patients with rare and serious diseases using antisense technology. Its primary focus is developing TEGSEDI, a therapy that treats the polyneuropathy caused by hereditary transthyretin-mediated amyloidosis in adults. It also offers a mature pipeline of novel drugs including AKCEA-APO(a)-LRx, AKCEA-ANGPTL3-LRx, and AKCEA-APOCIII-LRx. The company was founded in December 2014 and is headquartered in Cambridge, MA. | Health Technology |
Rallybio LLC
Rallybio LLC Miscellaneous Commercial ServicesCommercial Services Rallybio LLC operates as a development-stage biotechnology company. The firm develops transformative therapies for patients. It focuses on bringing life-transforming medicines to patients with devastating and rare disorder. The company was founded by Martin Mackay, Stephen Uden and Jeffrey Fryer in 2018 and is headquartered in Farmington, CT. | Commercial Services |
Dianthus Therapeutics, Inc. (Massachusetts)
Dianthus Therapeutics, Inc. (Massachusetts) BiotechnologyHealth Technology Dianthus Therapeutics OpCo, Inc. provides heath care services. The company was founded by Jonathan Violin and is headquartered in Waltham, MA. | Health Technology |
Ensoma, Inc.
Ensoma, Inc. Miscellaneous Commercial ServicesCommercial Services Ensoma, Inc. believes in the future of medicine and is committed to creating a new therapeutic category to tackle diseases that affect millions around the world, such as cancer and autoimmune disease, as well as inherited conditions. Ensoma is based in Boston, MA and has subsidiaries in Denmark. The company's engenious™ platform combines innovative delivery technology with the full DNA editing toolkit to address these disorders. Ensoma is supported by top-tier investors, a strategic collaboration with Takeda, and a passionate team. The company was founded by André Lieber, Hans-Peter Kiem, Kush M. Parmar, and the CEO is Emile F. Nuwaysir. | Commercial Services |
| Kyowa Kirin, Inc. | |
| JFYNetworks, Inc |
- Stock Market
- Insiders
- Paula Soteropoulos
